000257323 001__ 257323
000257323 005__ 20240808173023.0
000257323 0247_ $$2pmc$$apmc:PMC11102411
000257323 0247_ $$2doi$$a10.1007/s12311-023-01543-3
000257323 0247_ $$2pmid$$apmid:36922437
000257323 0247_ $$2ISSN$$a1473-4222
000257323 0247_ $$2ISSN$$a1473-4230
000257323 0247_ $$2altmetric$$aaltmetric:144046731
000257323 037__ $$aDZNE-2023-00392
000257323 041__ $$aEnglish
000257323 082__ $$a610
000257323 1001_ $$0P:(DE-2719)9001510$$aGrobe-Einsler, Marcus$$b0$$eFirst author$$udzne
000257323 245__ $$aScale for the Assessment and Rating of Ataxia (SARA): Development of a Training Tool and Certification Program.
000257323 260__ $$aLondon$$bDunitz$$c2024
000257323 3367_ $$2DRIVER$$aarticle
000257323 3367_ $$2DataCite$$aOutput Types/Journal article
000257323 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1716276806_21516
000257323 3367_ $$2BibTeX$$aARTICLE
000257323 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000257323 3367_ $$00$$2EndNote$$aJournal Article
000257323 500__ $$aCC BY
000257323 520__ $$aMonitoring of disease severity is of great importance for treatment and management of clinical trials. The Scale for Assessment and Rating of Ataxia (SARA) is a frequently used, short and easily applicable clinical scale used to assess the severity of ataxia. The objective of our study was to develop a training and certification tool for the SARA. SARA scores were recorded according to a standardized protocol and rated by three clinical experts in consensus. Four hundred thirty-eight videos of 67 patients were included in the SARA training tool. The tutorial section demonstrates a complete SARA examination on a healthy control. In the training section, users can compare their ratings to consensus ratings and access a video library covering the complete SARA range. The tool also includes a section that allows optional certification. The SARA training tool provides comprehensive and standardized training material and certification to reduce variability in applying the SARA. Standardization aims to improve the quality of patient care and research in ataxia.
000257323 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000257323 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000257323 650_7 $$2Other$$aAtaxia
000257323 650_7 $$2Other$$aCertification
000257323 650_7 $$2Other$$aSARA
000257323 650_7 $$2Other$$aTraining tool
000257323 650_2 $$2MeSH$$aHumans
000257323 650_2 $$2MeSH$$aAtaxia: diagnosis
000257323 650_2 $$2MeSH$$aAtaxia: therapy
000257323 650_2 $$2MeSH$$aCertification: standards
000257323 650_2 $$2MeSH$$aSeverity of Illness Index
000257323 650_2 $$2MeSH$$aFemale
000257323 650_2 $$2MeSH$$aMale
000257323 650_2 $$2MeSH$$aAdult
000257323 650_2 $$2MeSH$$aMiddle Aged
000257323 7001_ $$0P:(DE-2719)9000781$$aTaheri Amin, Arian$$b1$$udzne
000257323 7001_ $$0P:(DE-2719)2811327$$aFaber, Jennifer$$b2$$udzne
000257323 7001_ $$0P:(DE-2719)2810946$$aVölkel, Hartmut$$b3$$udzne
000257323 7001_ $$0P:(DE-2719)2811275$$aSynofzik, Matthis$$b4$$udzne
000257323 7001_ $$0P:(DE-2719)2810314$$aKlockgether, Thomas$$b5$$eLast author$$udzne
000257323 773__ $$0PERI:(DE-600)2071266-2$$a10.1007/s12311-023-01543-3$$n3$$p877 - 880$$tThe Cerebellum$$v23$$x1473-4222$$y2024
000257323 8564_ $$uhttps://pub.dzne.de/record/257323/files/DZNE-2023-00392.pdf$$yOpenAccess
000257323 8564_ $$uhttps://pub.dzne.de/record/257323/files/DZNE-2023-00392.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000257323 909CO $$ooai:pub.dzne.de:257323$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001510$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000781$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811327$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810946$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811275$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000257323 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810314$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000257323 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000257323 9141_ $$y2023
000257323 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-17
000257323 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000257323 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-17
000257323 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-17$$wger
000257323 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000257323 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCEREBELLUM : 2022$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-24
000257323 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-24
000257323 9201_ $$0I:(DE-2719)1011001$$kAG Klockgether$$lPatient Studies$$x0
000257323 9201_ $$0I:(DE-2719)1011103$$kAG Spottke$$lClinical Research Platform (CRP)$$x1
000257323 9201_ $$0I:(DE-2719)1011101$$kPatient Studies Bonn$$lPatient Studies Bonn$$x2
000257323 9201_ $$0I:(DE-2719)1011401$$kClinical Research Platform (CRP)$$lClinical Research Platform (CRP)$$x3
000257323 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x4
000257323 980__ $$ajournal
000257323 980__ $$aVDB
000257323 980__ $$aI:(DE-2719)1011001
000257323 980__ $$aI:(DE-2719)1011103
000257323 980__ $$aI:(DE-2719)1011101
000257323 980__ $$aI:(DE-2719)1011401
000257323 980__ $$aI:(DE-2719)1210000
000257323 980__ $$aUNRESTRICTED
000257323 9801_ $$aFullTexts